Klaviyo
KVYO
17.41
+0.81
+4.88%
Klaviyo
US · KVYO
#2180 by market cap
Listed 2023
17.41
+0.81
+4.88%
Live - 5344 symbols - heartbeat 210s ago
· 2026-10-08 07:58
Pre-market
17.25
-0.92%
After-hours
17.52
+0.63%
- Market cap
- 4.96B
- P/E (TTM)i
- 580.33
- P/Bi
- 5.13
- EPSi
- -0.11
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on KVYO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 8.31, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +31.63% YoY
Margins
- Gross margin
- 74.67%
- Operating margin
- -5.49%
- Net margin
- -2.57%
Key ratios & quality
- Altman Z-Scorei
- 8.31
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 290.64M | 472.75M | 698.10M | 937.46M | 1.23B |
| Gross profit | 205.94M | 344.72M | 520.21M | 716.16M | 921.50M |
| Selling & admin expenses | 219.58M | 295.68M | 588.66M | 561.78M | 698.05M |
| Research & development | 65.60M | 104.08M | 262.18M | 238.46M | 291.21M |
| Operating profit | -79.23M | -55.04M | -330.62M | -84.08M | -67.76M |
| Pretax profit | -79.07M | -49.11M | -307.04M | -43.68M | -30.52M |
| Tax | 319.00K | 83.00K | 1.19M | 2.46M | 1.25M |
| Net profit | -79.39M | -49.19M | -308.23M | -46.14M | -31.77M |
| Basic EPS | 0 | 0 | -1 | 0 | 0 |
| Diluted EPS | -0.32 | -0.20 | -1.27 | -0.17 | -0.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 279.83M | 293.12M | 310.88M | 350.20M | 358.01M | 370.58M |
| Gross profit | 212.13M | 221.88M | 234.74M | 252.75M | 268.89M | 269.10M |
| Selling & admin expenses | 166.53M | 180.75M | 172.91M | 177.86M | 187.12M | 192.13M |
| Research & development | 69.35M | 72.46M | 72.67M | 76.73M | 80.03M | 91.93M |
| Operating profit | -23.75M | -31.33M | -10.84M | -1.85M | 1.75M | -14.96M |
| Pretax profit | -15.16M | -22.48M | -614.00K | 7.73M | 10.72M | -7.11M |
| Tax | -1.07M | 1.80M | -188.00K | 704.00K | 1.68M | 1.74M |
| Net profit | -14.09M | -24.28M | -426.00K | 7.03M | 9.04M | -8.85M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.05 | -0.09 | 0.00 | 0.02 | 0.03 | -0.03 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 356.10M | 427.50M | 803.49M | 979.75M | 1.21B |
| Cash & ST investments | 327.91M | 385.82M | 738.56M | 881.47M | 1.06B |
| Inventory | -- | -- | -- | -- | -- |
| Total assets | 464.45M | 629.08M | 1.09B | 1.27B | 1.58B |
| Total current liabilities | 76.99M | 84.99M | 130.62M | 199.89M | 282.23M |
| Short-term debt | 9.10M | 14.86M | 14.08M | 20.99M | 24.76M |
| Long-term debt | -- | -- | -- | -- | -- |
| Total liabilities | 2,700,510,000.00 | 1,665,262,000.00 | 174,273,000.00 | 239,321,000.00 | 384,044,000.00 |
| Total equity | -2.24B | -1.04B | 914.78M | 1.03B | 1.20B |
| Retained earnings | -2.24B | -2.29B | -799.04M | -845.19M | -876.95M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.01B | 1.06B | 1.11B | 1.21B | 1.15B | 1.01B |
| Cash & ST investments | 888.43M | 935.52M | 980.27M | 1.06B | 984.59M | 832.64M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.35B | 1.40B | 1.47B | 1.58B | 1.52B | 1.38B |
| Total current liabilities | 192.82M | 214.24M | 227.50M | 282.23M | 271.05M | 322.13M |
| Short-term debt | 18.58M | 19.09M | 24.51M | 24.76M | 23.97M | 23.33M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 283,379,000.00 | 301,130,000.00 | 322,986,000.00 | 384,044,000.00 | 370,158,000.00 | 417,145,000.00 |
| Total equity | 1.06B | 1.10B | 1.14B | 1.20B | 1.15B | 967.02M |
| Retained earnings | -859.27M | -883.56M | -883.98M | -876.95M | -867.92M | -876.76M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -22.74M | -23.55M | 119.37M | 165.96M | 218.01M |
| Depreciation & amortization | 5.27M | 9.04M | 13.65M | 17.72M | 18.60M |
| Free cash flow | -36.97M | -41.80M | 110.01M | 148.73M | 189.54M |
| Dividends paid | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 205.31M | 99.56M | 320.10M | 0 | 0 |
| Ending cash balance | 327.91M | 386.92M | 739.66M | 882.59M | 1.07B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 14.36M | 55.73M | 54.76M | 93.16M | 34.28M | 93.88M |
| Depreciation & amortization | 4.78M | 3.93M | 4.38M | 5.51M | 6.34M | 7.27M |
| Free cash flow | 6.62M | 48.42M | 47.06M | 87.45M | 19.05M | 82.88M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -100.00M | -233.57M |
| Ending cash balance | 889.17M | 936.25M | 981.01M | 1.07B | 985.33M | 833.38M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -4.74 | -2.85 |
| ROA %i | -17.09 | -9.00 | -35.88 | -3.91 | -2.23 |
| ROIC %i | -- | -- | -- | -7.36 | -5.08 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | -27.20 | -10.39 | -43.98 | -8.97 | -5.49 |
| FCF / sales %i | -- | -- | 15.76 | 15.87 | 15.36 |
| Current ratioi | 4.63 | 5.03 | 6.15 | 4.90 | 4.27 |
| Quick ratioi | 4.34 | 4.67 | 5.83 | 4.63 | 3.99 |
| Debt / assetsi | 14.10 | 9.92 | 4.74 | 4.20 | 7.64 |
| LT debt / equityi | -- | -- | 4.10 | 3.14 | 8.02 |
| Interest coveragei | -9,883.25 | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 47.75 | 37.69 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -4.73 | -6.42 | -6.10 | -2.85 | -0.78 | 0.66 |
| ROA %i | -3.86 | -5.24 | -4.95 | -2.23 | -0.60 | 0.49 |
| ROIC %i | -7.12 | -8.63 | -8.19 | -5.08 | -2.66 | -1.53 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -8.51 | -9.55 | -8.71 | -5.49 | -3.22 | -1.86 |
| FCF / sales %i | 13.14 | 13.33 | 13.57 | 15.36 | 15.39 | 17.01 |
| Current ratioi | 5.22 | 4.95 | 4.88 | 4.27 | 4.23 | 3.13 |
| Quick ratioi | 4.89 | 4.64 | 4.58 | 3.99 | 3.90 | 2.83 |
| Debt / assetsi | 7.62 | 7.10 | 7.74 | 7.64 | 7.69 | 8.23 |
| LT debt / equityi | 7.91 | 7.30 | 7.78 | 8.02 | 8.08 | 9.37 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Providing software100.00%
Quote time 2026-10-08 07:58:01 · For reference only, not investment advice and not tailored to your situation.